REVERSPAH

Serial Number 90804894
606

Registration Progress

Application Filed
Jun 30, 2021
Under Examination
Jun 21, 2022
Approved for Publication
Apr 26, 2022
Published for Opposition
Apr 26, 2022
Registered

Trademark Image

REVERSPAH

Basic Information

Serial Number
90804894
Filing Date
June 30, 2021
Published for Opposition
April 26, 2022
Abandonment Date
January 23, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 23, 2023
Classes
005

Rights Holder

Erik Eglite

01
Address
875 Mellody Road
Lake Forest, IL 60045

Ownership History

Erik Eglite

Original Applicant
01
Lake Forest, IL

Erik Eglite

Owner at Publication
01
Lake Forest, IL

Legal Representation

Attorney
Erik Eglite

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Jan 23, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 23, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 21, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 26, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 26, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 6, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 23, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 23, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 23, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 23, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 23, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 21, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 13, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 3, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders

Classification

International Classes
005